文献速递骨质疏松与代谢性骨病创伤骨科

口服避孕药使用与骨折风险——英国12,970名女性的回顾性研究

Oral contraceptive use and fracture risk-a retrospective study of 12,970 women in the UK.
PubMed 文献 · Osteoporos Int · 2017-04-13

该回顾性巢式病例对照研究比较了英国135家全科诊所中6485例骨折女性与6485例无骨折女性的激素避孕暴露情况。无骨折女性使用口服避孕药的可能性显著更高(OR 0.81,95%CI 0.74-0.90),效应在18-25岁、26-35岁及用药超过1年者中最强。

要点

  • 无骨折女性使用口服避孕药的可能性显著更高(OR 0.81,95%CI 0.74-0.90)。
  • 效应在18-25岁和26-35岁年龄组及用药超过1年的患者中最强。
  • 作者指出无骨折女性暴露于复方口服避孕药的可能性显著更高,尤其用药至少5年者。

核心结论

  • 无骨折女性使用复方口服避孕药的可能性显著更高,尤其在用药至少5年者中。

研究设计与样本

  • 回顾性巢式病例对照研究,在英国135家全科诊所的疾病分析仪数据库中识别2010年1月至2015年12月间首次诊断骨折的6485名女性(平均年龄37.8岁),按年龄、索引年份和随访时间1:1匹配无骨折对照,共12,970人纳入分析。

主要发现

  • 无骨折女性使用口服避孕药的可能性显著更高(OR 0.81)。
  • 口服避孕药使用与骨折风险显著降低相关(OR 0.81,95%CI 0.74-0.90)。
  • 该效应在18-25岁和26-35岁年龄组及口服避孕药治疗持续时间超过1年的患者中最强。

关键数值与推荐

  • 口服避孕药使用与骨折风险降低相关(OR 0.81,95%CI 0.74-0.90)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: In the present retrospective case-control study, we compared 6485 women with fractures and 6485 women without fractures from 135 general practitioner offices in the UK. Women without bone fractures were statistically more likely to have been exposed to oral contraception, depending on their age and therapy duration. INTRODUCTION: The aim of this analysis was to compare the risk of bone fracture in women using hormonal contraception with that in women who have never used hormonal contraception. METHODS: A total of 6485 women (mean age 37.8 years) with an initial diagnosis of fracture between January 2010 and December 2015 were identified in 135 doctors' offices in the UK Disease Analyzer database. In this nested case-control study, each case with a fracture was matched (1:1) to a control without a fracture for age, index year, and follow-up time. In total, 12,970 individuals were available for analysis. The main outcome of the study was the risk of fracture as a function of combined oral contraceptive (OC) therapy. Multivariate logistic regression models were used to determine the effect of OC therapy and its duration on the risk of fracture in the entire population and in four age-specific subgroups. RESULTS: Women without bone fractures were significantly more likely to have used oral contraception (OR 0.81). The usage of oral contraception was associated with a significantly lower risk of bone fracture (OR 0.81, 95% CI 0.74-0.90). This effect was strongest in the age groups 18-25 and 26-35 and in patients with an OC treatment duration of more than 1 year. CONCLUSIONS: The present study revealed that women without bone fractures were significantly more likely to have had exposure to combined oral contraception, especially where the duration of intake was at least 5 years.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Dombrowski S, Jacob L, Hadji P, et al. Oral contraceptive use and fracture risk-a retrospective study of 12,970 women in the UK. Osteoporos Int. 2017. PMID: 28409216. doi:10.1007/s00198-017-4036-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。